Announcing Abzorba core technology - available to your organisation. It is an unmatched innovation. Very effective, proven organogel that is described as an anhydrous vegetable oil gel.
Abzorba skincare is a core technology excellent at trans-dermal migration from which a large array of very effective products can be made. It is suitable for cosmetics, cosmeceuticals and drugs and this includes veterinary. It is very effective for burns (at all degrees), wounds, and a wide array of skin disorders etc. including vaginal products. Many anecdotal testimonials are available from scientists and doctors for solicited enquiry and many OTC products are already developed.
We seek to talk with those who would truly value such a new technology for new products amongst their portfolio, disruptive in their respective market place.
A solution not an emulsion, anhydrous, many benefits come from this ...
Many OTC variants are already developed (all classed as cosmetics) and many variants can be used with ethical claims. A company can trade immediately in cosmetics and develop ethical to their own R&D goals. There is much anecdotal evidence of remarkable success with variants (i.e. burns, wounds, vaginal, diaper barrier, etc.). Of particular interest success with use in moist environments. OTC variants include sunscreens, various moisturisers and skin conditioners, anti-aging, barrier creams, hair products and more. There is room for extensive furtherance of R&D.
Abzorba technology has not been patented due to the fact it cannot be reverse engineered – even with all ingredients declared to the testing facilities. However patents can be applied should an investor require this to be done.
The FUTECNZ™ preference over expensive patent processes is simply to not reveal the exact process when ingredients have been shown. At the time of writing, the technology is unique to us and we seek a partner for their exclusive territory.
FUTECNZ™ Limited is a registered company in New Zealand.